Patent intelligence · GB
GB 2364308
AXOR64, a G-protein coupled receptor polypeptide and its encoding polynucleotide sequence
AXOR64, a G-protein coupled receptor polypeptide and its encoding polynucleotide sequence
Patent details — GB 2364308
- Jurisdiction
- GB
- Status
- expired
- Grant date
- Jan 23, 2002
- Expiration
- Jan 18, 2022
- Applicant
- SMITHKLINE BEECHAM CORP [US]
- CPC classes
- A61P 19/ 00 A I, A61P 21/ 00 A I, A61P 25/ 00 A I, A61P 35/ 00 A I
Quick answer
GB 2364308 (AXOR64, a G-protein coupled receptor polypeptide and its encoding polynucleotide sequence) is held by SMITHKLINE BEECHAM CORP [US]. Status: expired. Granted Jan 23, 2002. Expires Jan 18, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- SMITHKLINE BEECHAM CORP [US]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61P 19/ 00 A I, A61P 21/ 00 A I, A61P 25/ 00 A I, A61P 35/ 00 A I, A61P 37/ 00 A I, A61P/1900
More from SMITHKLINE BEECHAM CORP [US]
Related pharmaceutical patents in our USPTO index.
-
SA 92120308
تركيبة للاستخدام الموضعي topical composition
expired -
AT E269330
CHEMISCHE VERBINDUNGEN
expired -
EP 1425277
HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG
expired -
SA 91110341
مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus
expired -
HU P0302480
PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
expired -
AT E245157
3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
expired -
HK 1004528
Dentifrice compositions
expired -
HU P0204410
PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
expired
Frequently asked questions
What is US patent 2364308?
GB 2364308 (AXOR64, a G-protein coupled receptor polypeptide and its encoding polynucleotide sequence) is held by SMITHKLINE BEECHAM CORP [US]. Status: expired. Granted Jan 23, 2002. Expires Jan 18, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns GB 2364308?
SMITHKLINE BEECHAM CORP [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does GB 2364308 expire?
Our index shows an expiration date of Jan 18, 2022 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.